Company: INVUP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001493152-25-011912
Chunk: 40

Company: Investview, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 40
---
,416,665  
    $0.05  
    $0.03 
  
    Granted 
     -  
    $-  
    $- 
  
    Canceled/Expired 
     -  
    $-  
    $- 
  
    Exercised 
     -  
    $-  
    $- 
  
    Options outstanding at June 30, 2025 
     351,416,665  
    $0.05  
    $0.03 

Details
of our options outstanding as of June 30, 2025, are as follows:

 SCHEDULE OF OPTIONS OUTSTANDING

    Options Exercisable 
    Weighted Average Exercise Price of Options Exercisable  
    Weighted Average Contractual Life of Options Exercisable (Years)  
    Weighted Average Contractual Life of Options Outstanding (Years) 
  
    234,741,665 
     0.05  
     3.99  
     4.13 

Total
stock compensation expense related to the options for the six months ended June 30, 2025, and 2024, was $773,872 and $854,657, respectively.
As of June 30, 2025, there was approximately $2.5 million of unrecognized compensation cost related to the Options, which is expected
to be recognized over a remaining weighted-average vesting period of approximately 1.3 years.

Warrants

Transactions
involving our warrants are summarized as follows:

 SCHEDULE OF WARRANTS ISSUED

    Weighted 

    Number of  
    Average 

    Shares  
    Exercise Price 
  
    Warrants outstanding at December 31, 2024 
     1,178,090  
    $0.10 
  
    Granted 
     -  
    $- 
  
    Canceled/Expired 
     (77,345) 
    $0.10 
  
    Exercised 
     -  
    $- 
  
    Warrants outstanding at June 30, 2025 
     1,100,745  
    $0.10 

    23

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF JUNE 30, 2025

(Unaudited)

Details
of our